The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(69 - 75) Professional Services 72 - Scientific research and development 72.1 - Research and experimental development on natural sciences and engineering 72.10 - Research and experimental development on natural sciences and engineering
140 jobs Number of planned job creations
Announcement Date
7 December 2020
Employment effect (start)
7 December 2020
Foreseen end date
Description
Thermo Fisher Scientific Baltics, the American-capital company engaged in research and experimental development on biotechnology, intends to create 140 new jobs in Vilnius. The company is expanding its manufacturing capabilities of products for the life sciences market at the company’s site in Vilnius. It has already published at least 70 open positions for biotechnologists, scientists, chemists, quality control analysts and other positions on their webpage.
The managing director of Thermo Fisher Scientific Baltics said that 'the level of qualified candidates available' in Lithuania influenced their decision to expand Vilnius site, while the Lithuanian Minister of Economy and Innovation declared that the company’s expansion is 'a major step' toward achieving the goal of having life sciences yielding 5% of national GDP in 2030.
Thermo Fisher Scientific started its activities in Lithuania in 2010, when the company acquired a leading Lithuanian biotech company Fermentas for USD 260 million. Currently the company employs 1,260 employees. The site in Vilnius produces molecular, protein, and cellular biology products for research and diagnostics applications.
Thermo Fisher Scientific is one of the leading companies in serving science, with annual revenue exceeding USD 25 billion. It has a global team of more than 75,000 people worldwide. The company is known for its industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.
Eurofound (2020), Thermo Fisher Scientific Baltics, Business expansion in Lithuania, factsheet number 102751, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/102751.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...